This has been applied to capture the heterogeneity in EGFRvIII status72,73, IDT mutational status74–78, 1p/19q co-deletion75, MGMT status75, GBM subtype79 and tumor molecular pathways80–83. This evidence concerns the gene MGMT and neoplasm.